Ceftazidime Powder For Solution Suppliers & Bulk Manufacturers
Available Forms: Powder for Solution
Available Strengths: 1 g, 2 g, 2.5 g, 3 g, 4 g
Reference Brands: Fortaz, Tazicef(US& EU)
Category:
Antibiotics
Ceftazidime suspension inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis. It is effective against gram-negative bacteria, including Pseudomonas aeruginosa. Benefits include targeted, reliable oral therapy for pediatric or outpatient infections, rapid bacterial clearance, broad-spectrum activity, and convenience in managing serious infections in children.
Ceftazidime Powder for Solution is available in Powder for Solution
and strengths such as 1 g, 2 g, 2.5 g, 3 g, 4 g.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ceftazidime Powder for Solution is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ceftazidime Powder for Solution can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ceftazidime suspension is approved in the EU and US for treating severe gram-negative bacterial infections, particularly in pediatric patients. In the EU, brands like Fortaz and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on comprehensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality standards, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for ceftazidime suspension, ensuring adherence to European and US standards for safe, effective therapy in serious infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing